author-photo

Chinami Masuda

Chugai Pharmaceutical Co.

4

Papers

59

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

PD-L1 blockade exhibits anti-tumor effect on brain metastasis by activating CD8+ T cells in hematogenous metastasis model with lymphocyte infusion.

2021 Clinical & Experimental Metastasis
Show All
- Source
- Cite
- Save
Citations (0)
Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model

2019 Clinical & Experimental Metastasis
Show All
- Source
- Cite
- Save
Citations (11)
MALDI mass spectrometry imaging of erlotinib administered in combination with bevacizumab in xenograft mice bearing B901L, EGFR-mutated NSCLC cells

2017 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (7)
Bevacizumab counteracts VEGF-dependent resistance to erlotinib in an EGFR-mutated NSCLC xenograft model

2017 International Journal of Oncology
Show All
- Source
- Cite
- Save
Citations (41)